ESCMID Publications

ESCMID Panorama

Medical Guideline Publications in 2017

For a complete list of medical guideline publications in 2017, please have a look at the Publications page

Clin Microbiol Infect 2016; 22 (Suppl. 4)

Published guideline (published online: 22 July 2016)

This guideline was coordinated by the ESCMID Study Group for Clostridium difficile (ESGCD)

Guideline development history:

Clin Microbiol Infect 2016; 22 (Suppl. 3)

Published guideline (published online: 7 April 2016)

This guideline was coordinated by the ESCMID Study Group for Infections of the Brain (ESGIB)

Guideline development history:

Clin Microbiol Infect 2015; 21 (Suppl. 1)

Coordinated by the ESCMID Study Group for Biofilms (ESGB)

ESCMID and ECMM guidelines for the management of rare and emerging fungal infections

Clin Microbiol Infect 2014; 20 (Suppl. 3)

Coordinated by the ESCMID Fungal Infection Study Group (EFISG)

Editorial

O. A. Cornely et al.

Pages 1-4

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013

O. A. Cornely et al.

Pages 5-26

ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others

A. M. Tortorano et al.

Pages 27-46

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi

A. Chowdhary et al.

Pages 47-75

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections

M. C. Arendrup et al.

Pages 76-98

Clin Microbiol Infect 2014; Vol 20 (Suppl s2), pp 1–26

The previous European Society of Clinical Microbiology and Infection (ESCMID) guidance document, which has been applied widely in clinical practice, dates from 2009. Meanwhile, new treatments for Clostridium difficile infection (CDI) have been developed and limitations of the currently recommended treatment options of CDI are considered. As the current ESCMID treatment guidance document is already implemented in clinical practice, an update of this widely applied guidance document is essential to further improve uniformity of national hospital infection treatment policies for CDI in Europe.

Clin Microbiol Infect 2014; Vol 20 (Suppl s1), pp 1–55

Healthcare-associated infections due to multidrug-resistant Gram-negative bacteria (MDR-GNB) are a leading cause of morbidity and mortality worldwide. These evidence-based guidelines have been produced after a systematic review of published studies on infection prevention and control interventions aimed at reducing the transmission of MDR-GNB. The recommendations are stratified by type of infection prevention and control intervention and species of MDR-GNB and are presented in the form of ‘basic’ practices, recommended for all acute care facilities, and ‘additional special approaches’ to be considered when there is still clinical and/or epidemiological and/or molecular evidence of ongoing transmission, despite the application of the basic measures. The level of evidence for and strength of each recommendation, were defined according to the GRADE approach.

ESCMID guideline for the diagnosis and management of Candida diseases 2012

Clin Microbiol Infect 2012; 18 (Suppl. 7)

Coordinated by the ESCMID Fungal Infection Study Group (EFISG)

Developing European guidelines in clinical microbiology and infectious diseases

A. J. Ullmann et al.

Pages 1-8

Diagnostic procedures

M. Cuenca-Estrella et al.

Pages 9-18

Non-neutropenic adult patients

O. A. Cornely et al.

Pages 19-37

Prevention and management of invasive infections in neonates and children caused by Candida spp.

W. W. Hope et al.

Pages 38-52

Adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)

A. J. Ullmann et al.

Pages 53-67

Patients with HIV infection or AIDS

O. Lortholary et al.

Pages 68-77

ESCMID Sore Throat Guideline Group

C. Pelucchi, L. Grigoryan, C. Galeone, S. Esposito, P. Huovinen, P. Little and T. Verheij. Clin Microbiol Infect 2012; 18 (Suppl. 1): 1–27

Full text

M. P. Bauer, E. J. Kuijper and J. T. van Dissel, Clin Microbiol Infect 2009; 15: 1067–1079

M. J. T. Crobach, O. M. Dekkers, M. H. Wilcox and E. J. Kuijper, Clin Microbiol Infect 2009; 15: 1053–1066

Guidelines for the validation and application of typing methods for use in bacterial epidemiology

A. van Belkum et. al on behalf of the ESCMID Study Group on Epidemiological Markers (ESGEM), Clin Micro Biol Infect 2007: 13 (Suppl. 3): 1-46

download

Guidelines for the management of adult lower respiratory tract infections

M. Woodhead et al., Eur Respir J 2005 26: 1138-1180

download

Guidelines for the management of adult lower respiratory tract infections. Appendices

M. Woodhead et al.

download

European recommendations for antimicrobial resistance surveillance

G. Cornaglia et al., ESCMID Study Group for Antimicrobial Resistance Surveillance (ESGARS), Clin Microbiol Infect 2004 10: 349-383

download

Guidelines for the diagnosis of tick-borne bacterial diseases in Europe

P. Brouqui et al., ESCMID Study Group on Coxiella, Anaplasma, Rickettsia and Bartonella (ESCAR) and the European Network for Surveillance of Tick-Borne Diseases, Clin Microbiol Infect 2004 10: 1108-1132

download

A European survey of diagnostic methods and testing protocols for Clostridium dificile

Barbut et al., ESCMID Study Group on Clostridium difficile (ESGCD), Clin Microbiol Infect 2003 9: 989-996

download

Last update: 23 August 2016

Do you need funding for guideline production?

Detailed guidance is provided in the ESCMID Operating Procedures for Medical Guidelines.

EOPs for Medical Guidelines